Pre-doctoral Research Fellow
Pubblicato il 14-09-2026 - Altro in Rozzano
Contract type: A 1-year research contract starting from January 2027, with the possibility of progression to a 3-year PhD program (December 2027-December 2030) at Humanitas University.
Why Humanitas Choosing Humanitas means joining an environment where quality of care is built every day through clinical expertise, innovation and teamwork, where everyone contributes to the patient care journey.
Who we are Humanitas Research Hospital is a highly specialized research and university hospital, and the first in Italy to be certified as an Academic Hospital by the Joint Commission International. Research is driven daily by over 500 physicians, biologists, physicists, data scientists, and technologists working across hospital wards and 10,000 sqm of high-tech laboratories. Our mission is to transform discoveries into concrete cures, with a strategic focus on five key areas: cancer, immunology, neuroscience, gastrointestinal medicine, and molecular cardiology.
The context We are seeking a highly motivated and talented pre-doctoral research fellow to join the project “Deciphering the A-to-I RNA Editing Contribution to Cardiac Remodeling and Heart Failure: A Novel Therapeutic Approach” (EDICARE), funded by the Italian Ministry of Health.
The position will be available from January 2027 and will be based at the Cardio Center of Humanitas Research Hospital in Milan, Italy. The successful candidate will work under the supervision of the project’s Principal Investigator, Dr. Valeriana Cesarini.
The EDICARE project aims to elucidate the role of A-to-I RNA editing, mediated by ADAR1 and ADAR2 enzymes, in cardiac remodeling and heart failure. The research integrates omics approaches, in vivo mouse models of heart failure, and in vitro systems with the goal of identifying RNA editing-based therapeutic strategies and novel prognostic biomarkers.
Key tasks and responsibilities Maintenance of induced pluripotent stem cells (iPSCs) and cardiomyocyte cultures.
Design and evaluation of anti